Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma.

Abstract

Ipilimumab and radiotherapy are commonly used to treat unresectable and metastatic melanoma. Results from preclinical studies and case reports suggest a biologic interaction between these two treatments. To understand the clinical implications of the interaction, we carried out a retrospective study reviewing records of patients treated with ipilimumab and… (More)
DOI: 10.1158/2326-6066.CIR-13-0082

3 Figures and Tables

Topics

  • Presentations referencing similar topics